Clinical Trials in Georgia

Showing 4521-4540 of 14,426 trials

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

NCT06128369

The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.

Inflammation EyePain, PostoperativeCataract

Oculis117 participantsStarted Dec 2023

Inglewood, California, United States • Morrow, Georgia, United States • Louisville, Kentucky, United States +9 more locations

TERMINATEDPhase 263 miles

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

NCT05476783

This is an open-label long term extension study for participants with Alzheimer's disease (AD) who have completed Protocol TB006AD2102 (lead-in study) or participants who would have been eligible for the lead-in study but were not enrolled (de novo). The study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TB006. The total study duration for each participant will be up to 113 weeks.

Alzheimer's Disease

TrueBinding, Inc.180 participantsStarted Sep 2022

San Diego, California, United States • Delray Beach, Florida, United States • Lady Lake, Florida, United States +10 more locations

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Find Trials by Condition in Georgia

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Comprehensive Outcomes for After Cancer Health

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

SpineJack System Postmarket Registry

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

Osia 2 Pediatric Expansion Study

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies